# 2026-13164: Official U.S. Pharmacopeia Wants to Import Marijuana

2026-13164, Importer of Controlled Substances Application: United States Pharmacopeial Convention, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2026-06-30, effective Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on, or objections to the issuance of the proposed registration on or before July 30, 2026. Such persons may also file a written request for a hearing on the application on or before July 30, 2026. (as of 2026-07-07).

- Canonical: https://policyrisk.com/federal-register/2026-13164
- As of: 2026-07-07
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-13164
- Title: Importer of Controlled Substances Application: United States Pharmacopeial Convention
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 91 FR 39637
- Published: 2026-06-30
- Effective: Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on, or objections to the issuance of the proposed registration on or before July 30, 2026. Such persons may also file a written request for a hearing on the application on or before July 30, 2026.
- Comments close: 2026-07-30
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-07-07

## In one line

Official U.S. Pharmacopeia Wants to Import Marijuana

## Summary

The United States Pharmacopeial Convention wants to become an official importer of certain controlled substances like marijuana and its extracts. If you’re a registered manufacturer or interested party, you have until July 30, 2026, to share your thoughts or ask for a hearing. This move could impact how these substances are brought into the U.S., so keep an eye on the deadlines and get involved if it affects you!

## Abstract

United States Pharmacopeial Convention has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

## Effects PRIA read

- Comment and Hearing Deadline: benefit, low. United States Pharmacopeial Convention applied on June 1, 2026 to be registered as an importer of Marihuana (drug code 7360) and Marihuana Extract (drug code 7350), both Schedule I. Registered bulk manufacturers and applicants may submit comments or requests for a hearing electronically or in writi…
- Import for Analytical Reference Standards: benefit, low. The applicant seeks authorization to import Marihuana (7360) and Marihuana Extract (7350) for distribution as analytical reference standards to customers for analytical testing of raw materials. The application filed June 1, 2026 states no other activities for these drug codes are authorized under…
- Finished Dosage Forms Excluded: cost, low. The notice expressly states that authorization will not extend to the import of Food and Drug Administration-approved or non-approved finished dosage forms for commercial sale. Entities seeking to import finished marijuana products for commercial sale would not be authorized under this registration.

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2026-13164 on federalregister.gov](https://www.federalregister.gov/documents/2026/06/30/2026-13164/importer-of-controlled-substances-application-united-states-pharmacopeial-convention)
- [2026-13164 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-06-30/pdf/2026-13164.pdf)

## Related
- [Previous: 2026-13163, Notification of Cancelled Adjustment of Civil Monetary Penalties for Inflation](https://policyrisk.com/federal-register/2026-13163)
- [Next: 2026-13165, Notice of Proposed Buy America Waiver for North County Transit District DMU Rep…](https://policyrisk.com/federal-register/2026-13165)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-13164 (as of 2026-07-07).
